Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33411586

Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Apr 1
First author
Patel KK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Patel KK
      type
      Author
    2. name
      Giri S
      type
      Author
    3. name
      Parker TL
      type
      Author
    4. name
      Bar N
      type
      Author
    5. name
      Neparidze N
      type
      Author
    6. name
      Huntington SF
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Patel KK
      type
      Author
    2. name
      Giri S
      type
      Author
    3. name
      Parker TL
      type
      Author
    4. name
      Bar N
      type
      Author
    5. name
      Neparidze N
      type
      Author
    6. name
      Huntington SF
      type
      Author
    bibliography ids
    1. nci-bib-b2d30f09c78d3a0be1b2e587
    book metadata
    content sha256
    b6b954973f3409476e8566218ea174a3c0e0b729fb19a7514c12b938dff04176
    document type
    citation
    dois
    1. 10.1200/JCO.20.01849
    electronic publication date
    display
    2021 Jan 7
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33411586
    immutable id
    pubmed:33411586@b6b954973f3409476e8566218ea174a3c0e0b729fb19a7514c12b938dff04176
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    10
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1119-1128
    volume
    39
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33411586
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      dc49fb4da8e03e7a4200ca5305701a676a4eb204e2f014522ddb273f48bde90a
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Apr 1
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33411586/
      title
      Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma.

      Preserved source evidence · Not medical advice